CD40 and neoplasm: A further understanding of the mechanisms of CD40 signalling pathway-mediated inflammatory E-cadherin + DC differentiation in innate immunity and the tumour microenvironment may provide novel therapeutic strategies and insight into the pathogenesis of NSCLC.